SCC-Ag, lymph node metastases and sentinel node procedure in early stage squamous cell cervical cancer

Gynecologic Oncology

Volumn 112, Issue 1, 2009, Pages 119-125

  van de Lande, Jonas ^a   Davelaar, Elvira M ^a   von Mensdorff Pouilly, Silvia ^a   Water, Tatjana J ^a   Berkhof, Johannes ^a   van Baal, W Marchien ^a   Kenemans, Peter ^a   Verheijen, René H M ^b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Early stage cervical cancer; Lymph node metastases; prognosis; SCC Ag; Sentinel node; Squamous cell carcinoma

Indexed keywords

TUMOR ANTIGEN;

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; DIAGNOSTIC ACCURACY; DISEASE MARKER; FEMALE; HUMAN; LAPAROSCOPY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PELVIS LYMPHADENECTOMY; PRIORITY JOURNAL; PROGNOSIS; SENTINEL LYMPH NODE BIOPSY; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CANCER;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SENTINEL LYMPH NODE BIOPSY; SERPINS; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 57649096290     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2008.09.042     Document Type: Article

References (29)

1. Parkin D.M., Bray F., Ferlay J., and Pisani P. Global cancer statistics, 2002. CA Cancer J. Clin. 55 (2005) 74-108
2. Creasman W.T. New gynecologic cancer staging. Gynecol. Oncol. (1995) 58157-58158
3. Delgado G., Bundy B.N., Zaino R., Sevin B.U., Creasman W.T., and Major F. Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. Gynecol. Oncol. 38 (1990) 352-357
4. Sakuragi N. Up-to-date management of lymph node metastasis and the role of tailored lymphadenectomy in cervical cancer. Int. J. Clin. Oncol. 12 (2007) 165-175
5. Petignat P., and Roy M. Diagnosis and management of cervical cancer. Br. Med. J. 335 (2007) 765-768
6. Kato H., Tamai K., Morioka H., Nagai M., Nagaya T., and Torigoe T. Tumor-antigen TA-4 in the detection of recurrence in cervical squamous carcinoma. Cancer 54 (1984) 1544-1546
7. Bonfrer J.M.G., Gaarenstroom K.N., Korse C.M., Van Bunningen B.N.F.M., and Kenemans P. Cyfra 21-1 in monitoring cervical cancer. A comparison with tissue polypeptide antigen and squamous cell carcinoma antigen. Anticancer Res. 17 (1997) 2329-2334
8. Esajas M.D., Duk J.M., De Bruijn H.W.A., Aalders J.G., Willemse P.H.B., Sluiter W., et al. Clinical value of routine serum squamous cell carcinoma antigen in follow-up of patients with early-stage cervical cancer. J. Clin. Oncol. 19 (2001) 3960-3966
9. Pras E., Willemse P.H.B., Canrinus A.A., De Bruijn H.W.A., Sluiter W.J., Ten Hoor K.A., et al. Serum squamous cell carcinoma antigen and CYFRA 21-1 in cervical cancer treatment. Int. J. Rad. Oncol. Biol. Phys. 52 (2002) 23-32
10. Åvall-Lundqvist E.H., Sjövall K., Nilsson B.R., and Eneroth P.H.E. Prognostic significance of pre-treatment serum levels of squamous cell carcinoma antigen and CA125 in cervical carcinoma. Eur. J. Cancer 28A (1992) 1695-1702
11. Duk J.M., Groenier K.H., de Bruijn H.W.A., Hollema H., ten Hoor K.A., van der Zee A.G.J., et al. Pretreatment serum squamous cell carcinoma antigen: a newly identified prognostic factor in early-stage cervical carcinoma. J. Clin. Oncol. 14 (1996) 111-118
12. Takeda M., Sakuragi N., Okamoto K., Todo Y., Minobe S.I., Nomura E., et al. Preoperative serum SCC, CA125, and CA19-9 levels and lymph node status in squamous cell carcinoma of the uterine cervix. Acta Obstet. Gynecol. Scand. 81 (2002) 451-457
13. Yuan C.C., Wang P.H., Ng H.T., Tsai L.C., Juang C.M., and Chiu L.M. Both TPA and SCC-Ag levels are prognostic even in high-risk stage Ib-IIa cervical carcinoma as determined by stratification analysis. Eur. J. Gynaecol. Oncol. 23 (2002) 17-20
14. Strauss H.G., Laban C., Lautenschläger C., Buchmann J., Schneider I., and Koelbl H. SCC antigen in the serum as an independent prognostic factor in operable squamous cell carcinoma of the cervix. Eur. J. Cancer 38 (2002) 1987-1991
15. Molina R., Filella X., Lejarcegui J.A., Pahisa J., Torné A., Rovirosa A., et al. Prospective evaluation of squamous cell carcinoma and carcinoembryonic antigen as prognostic factors in patients with cervical cancer. Tumor Biol. 24 (2003) 156-164
16. Reesink-Peters N., van der Velden J., ten Hoor K.A., Boezem H.M., de Vries E.G.E., Schilthuis M.S., et al. Preoperative serum squamous cell carcinoma antigen levels in clinical decision making for patients with early-stage cervical cancer. J. Clin. Oncol. 23 (2005) 1455-1462
17. Bolger B.S., Dabbas M., Lopes A., and Monaghan J.M. Prognostic value of preoperative squamous cell carcinoma antigen levels in patients surgically treated for cervical carcinoma. Gynecol. Oncol. 65 (1997) 309-313
18. Gaarenstroom K.N., Kenter G.G., Bonfrer J.M., Korse C.M., Hart A.A., Van de Vijver M.J., et al. Can initial serum CYFRA 21-1, SCC antigen, and TPA levels in squamous cervical cancer predict lymph node metastases or prognosis?. Gynecol. Oncol. 77 (2000) 164-170
19. Buist M.R., Pijpers R.J., van Lingen A., van Diest P.J., Dijkstra J., Kenemans P., et al. Laparoscopic detection of sentinel lymph nodes followed by lymph node dissection in patients with early stage cervical cancer. Gynecol. Oncol. 90 (2003) 290-296
20. Gaarenstroom K.N., Bonfrer J.M., Kenter G.G., Korse C.M., Hart A.A., Trimbos J.B., et al. Clinical value of pretreatment serum Cyfra 21-1, tissue polypeptide antigen, and squamous cell carcinoma antigen levels in patients with cervical cancer. Cancer 76 (1995) 807-813
21. Zweig M.H., and Campbell G. Receiver-operating characteristics (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin. Chem. 39 (1993) 561-577
22. Cox D.R. Regression models and life tables. J. R. Stat. Soc. B 34 (1972) 187-220
23. Davelaar E.M., van de Lande J., von Mensdorff-Pouilly S., Blankenstein M.A., Verheijen R.H.M., and Kenemans P. A combination of serum tumor markers identifies high-risk patients with early-stage squamous cervical cancer. Tumor Biol. 29 (2008) 9-17
24. Kaplan E.L., and Meier P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 53 (1958) 457-481
25. Landoni F., Maneo A., Colombo A., Placa F., Milani R., Perego P., et al. Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet 350 (1997) 535-540
26. Van de Lande J., Torrenga B., Raijmakers P.G.H.M., Hoekstra O.S., van Baal M.W., Brölmann H.A.M., et al. Sentinel lymph node detection in early stage uterine cervix carcinoma: a systematic review. Gynecol. Oncol. 106 (2007) 604-613
27. Altgassen C., Hertel H., Brandstädt A., Köhler C., Dürst M., and Schneider A. Multicenter validation study of the sentinel lymph node concept in cervical cancer: AGO study group. J. Clin. Oncol. 26 (2008) 2943-2951
28. Van Trappen P.O., Gyselman V.G., Lowe D.G., Ryan A., Oram D.H., Bosze P., et al. Molecular quantification and mapping of lymph node micrometastases in cervical cancer. Lancet 357 (2001) 15-20
29. Lentz S.E., Muderspach L.I., Felix J.C., Ye W., Groshen S., and Amezcua C.A. Identification of micrometastases in histologically negative lymph nodes of early-stage cervical cancer patients. Obstet. Gynecol. 103 (2004) 1204-1210